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Abstract 
Atrial fibrillation is the most common arrhythmia in the healthcare setting. As of 2010, 
there were 33.5 million Americans living with atrial fibrillation in the United States. It is a 
chronic condition that requires continuous education by healthcare providers in primary care and 
specialty settings. The purpose of this quality improvement project was to determine if providing 
patient education via the CardioVisual mobile application to patients newly diagnosed with atrial 
fibrillation increased patient knowledge regarding atrial fibrillation and improved medication 
adherence to anticoagulant therapy in three months. This project used a quasi-experimental pre-
test/post-test design. Participants were asked to complete the Jessa Atrial Fibrillation Knowledge 
Questionnaire and the Measurement of Treatment Adherence tool prior to the intervention and 
three months after the intervention. The project was conducted at two cardiology clinics in 
Kansas City, Missouri. The participants were men and women age 40 to 75 newly diagnosed 
with atrial fibrillation in the last year. The sample size was 28 participants. The primary outcome 
was atrial fibrillation patient knowledge. General patient knowledge about atrial fibrillation and 
anticoagulants improved after the educational intervention. The secondary outcome evaluated 
was adherence to anticoagulant therapy. Overall adherence to anticoagulant therapy increased 
after the educational intervention. Through the use of CardioVisual, patients engaged in shared 
decision-making and made informed decisions about the individualized healthcare plan.  
Keywords: atrial fibrillation, anticoagulation, adherence, education, CardioVisual 
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Atrial Fibrillation Patient Education: An Evidence-Based Project  
Atrial fibrillation is the most common cardiac arrhythmia. It is a leading cause of 
ischemic stroke and carries a mortality rate of 1.6-4.2% each year in the United States 
(Sankaranarayanan et al., 2015). Atrial fibrillation is an independent risk factor for stroke and 
anticoagulation therapy is required to reduce the risk of ischemic stroke and mortality 
(Clarkesmith et al., 2017). Patients who are newly diagnosed with atrial fibrillation do not often 
have a significant understanding of their diagnosis, treatment options, and risk for complications 
including ischemic stroke. Education is required from the onset of the disease process throughout 
the patient’s lifespan via ongoing provider-patient communication and education at every patient 
encounter.  
Significance 
Atrial fibrillation is a growing problem in today’s healthcare system. As of 2010, the 
global burden of atrial fibrillation had reached 33.5 million individuals (Guo et al., 2017). The 
risk of developing atrial fibrillation is 21 to 23 percent in women and 17 to 26 percent in men. 
With the aging population, a 5-fold increase in the number of individuals with atrial fibrillation is 
predicted by 2050 (Guo et al., 2017). Atrial fibrillation is a leading cause of ischemic stroke, 
accounting for 15 to 25 percent of all ischemic strokes. Strokes resulting from atrial fibrillation 
are associated with frequent fatalities and severe debilitation (Salmasi et al., 2018).  
A key component of atrial fibrillation management is anticoagulation for stroke 
prevention. Patients have varying levels of understanding about the reasons for anticoagulation 
medications, medication actions, and long-term anticoagulation with elevated stroke risk. Poor 
understanding of anticoagulation leads to non-adherence, which places patient at greater risk of 
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stroke (Clarkesmith, Pattison, Lip, & Lane, 2013). Providing education to patients regarding 
anticoagulation adherence aides in reduction of stroke risk and adverse patient outcomes.  
Local Issue 
This project was conducted in Kansas City, Missouri at two cardiology clinics located in 
Jackson County. Limited data was available regarding atrial fibrillation incidence, prevalence, 
and mortality for the local population of interest for this project. However, significant data was 
available regarding ischemic stroke in Jackson County. The available statistics from the Missouri 
Department of Health and Senior Services suggested that ischemic stroke accounted for over 
6000 hospital admissions between 2011 and 2015 in Jackson County. The mortality rate for 
stroke and other cerebrovascular disease between 2007 and 2017 was 42% overall, with ischemic 
stroke accounting for 174 deaths (Missouri Department of Health & Senior Services, 2017). This 
data demonstrated a need for improved education regarding atrial fibrillation and the importance 
of medication adherence, including anticoagulation.   
Diversity Considerations 
The clinical project was conducted two cardiology clinics in Kansas City, Missouri. The 
demographics in Jackson County include a variety of races, including Caucasian, African 
American, American Indian/Alaskan Native, Asian, and Native Hawaiian/Pacific Islander. The 
primary race in Jackson County is Caucasian (73.9%), followed by African American (12.96%). 
The primary ethnicity represented in Jackson County is Non-Hispanic/Latino at 86.36% of the 
total population (KC HealthMatters, 2019). Patients are seen in the clinic from a variety of 
locations including inner-city, suburban, and rural locations. Patients with newly diagnosed atrial 
fibrillation are seen at these locations from a wide distribution of races, ethnicities, and locations.  
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Problem Statement 
Patients who are newly diagnosed with atrial fibrillation struggle with knowledge deficits 
regarding their diagnosis, treatment options, and risk for adverse events due to non-adherence, 
including ischemic stroke which can result in severe debilitation and death. A problem exists 
with knowledge dissemination for patients newly diagnosed with atrial fibrillation. The current 
information available to the public via the internet, including YouTube and Google searches, is 
not evidence-based and provide inaccurate information. Additionally, few mobile applications 
are available for download in the United States that provide education for patients with atrial 
fibrillation.  
Intended Improvement and Purpose Statement 
The trigger for change at the cardiology clinic was the increasing number of patients who 
were diagnosed with atrial fibrillation and the potential complications due to medication non-
adherence. Additionally, a shift towards shared decision-making has occurred in outpatient 
specialty care, including cardiology and electrophysiology. A strong need was present for 
patients to have access to evidence-based education regarding atrial fibrillation and the available 
treatment options. The intended improvement was triggered by the healthcare team to increase 
patient knowledge and improve anticoagulant therapy adherence. The purpose of the proposed 
quasi-experimental project was to determine if providing education to patients newly diagnosed 
with atrial fibrillation via the CardioVisual mobile application over three months a) increased 
patient knowledge regarding atrial fibrillation and b) improved adherence to anticoagulation 
therapy (see Appendix A for definition of terms). 
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Facilitators and Barriers 
Four main facilitators were identified for this project. The first facilitator was the support 
from stakeholders in the organization. The electrophysiology physicians, nurse practitioners, and 
support staff in the electrophysiology department were in favor of this project. The project was 
reviewed with the stakeholders and each person offered their support of the project. They were 
also interested in exploring the mobile application to review the resources available.  
 The second facilitator was the minimal expense for the project. The project did not 
require many resources from the clinic and the mobile application itself is free for patient and 
provider use. The third facilitator was the minimal time required from other support staff 
members. The project team leader was the primary contact person and the only person to 
administer the pre/post tests and assist patients with downloading the mobile application.  
 The fourth facilitator was the existing evidence to support the project. Several existing 
evidence-based practice guidelines, as well as standards of practice address health promotion that 
aligned with the project. Health promotion is a leading effort in today’s healthcare system that is 
occurring at the local, state, and national levels. The American Heart Association and the 
American Stroke Association, are leading the way in health promotion through stroke and 
cardiac disease prevention at the national level. Their guidelines and initiatives were used in 
development of the evidence-based project. 
 Two potential barriers were identified for this project. The first barrier was the potential 
of patients not having a smartphone or tablet or not wishing to download a mobile application. 
The second barrier was the possible low number of patients seen by electrophysiology providers 
at the clinic locations who align with the target population. Each of these barriers carried the 
potential to impact the quantity of data and strength of the project. One potential barrier to the 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
7
change process was provider time required to assist patients in downloading the mobile 
application. This barrier to change can be overcome by providing patients with the QR code for 
the application and a handout with step-by-step instructions to access the education for atrial 
fibrillation.  
Inquiry 
The inquiry for this DNP project was: In patients age 40-75 with newly diagnosed atrial 
fibrillation within the last 365 days, does education provided via the CardioVisual mobile app, 
compared to current education provided by Heart Rhythm Society brochures, increase patient 
knowledge of atrial fibrillation and improve anticoagulation adherence in three months at a 
cardiology clinic? 
Search Strategies 
The literature search for this project was conducted primarily through the University of 
Missouri-Kansas City Health Science Library and Google Scholar. Specific databases included 
EBSCO host, CINAHL, and Scopus. Keywords for the search included atrial fibrillation, 
education, patient, adherence, and anticoagulation. The inclusion criteria comprised studies 
published between 2014 and 2019, using the priority key words from healthcare-related journals 
only. Exclusion criteria included studies not published in English and studies that were 
conducted in emergency room settings.  
 The literature search yielded 24 total articles where were categorized into three themes 
(see Appendix B for a detailed evidence table). Each article was appraised utilizing Melnyk’s 
levels of evidence (Melnyk & Fineout-Overholt, 2015, adapted). For patient experience and 
baseline knowledge, there were 14 total articles. Three studies were level II studies and consisted 
of randomized controlled trials and two level III single quantitative studies. One study was level 
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IV, a quantitative cohort study. Two studies were qualitative systematic reviews, level V 
evidence. Six studies were identified as level VI evidence, all of which were single qualitative 
studies.  
 The theme of health literacy yielded three articles. One single quantitative study was 
identified as level III evidence. Two studies were identified as level IV evidence, which 
consisted of a quantitative cohort study and a cross-sectional study. The third theme of shared 
decision-making yielded seven articles. There was one level I systematic review. Three level VI 
studies were identified, which included single qualitative studies. Three articles were identified 
as level VII, both of which were expert opinions regarding shared decision-making (Melnyk & 
Fineout-Overholt, 2015, adapted).  
Evidence by Themes 
Through a review of current literature, three themes were identified from the evidence. 
The primary leading theme identified was patient experience and baseline knowledge; second 
was health literacy; and the third shared decision-making. Each theme yielded substantial 
evidence to validate the inquiry of the project (see Appendix C for a detailed PRISMA diagram).  
Patient Experience and Baseline Knowledge 
 An awareness of patient’s baseline knowledge and beliefs about the treatment plan is 
essential for healthcare providers to consider (Clarkesmith et al., 2017; Dalmau et al., 2017; 
Lane, Barker, & Lip, 2015; Lindberg, Berglund, Elmstahl, & Bohman, 2017; McCabe, Rhudy, & 
DeVon, 2014)Salmasi et al., 2018). It is vital that patients understand the severity of atrial 
fibrillation and the need for anticoagulation therapy and rhythm management. Providers should 
evaluate patients’ existing knowledge regarding atrial fibrillation before providing individualized 
education to eliminate the influence of inaccurate knowledge or biases about atrial fibrillation 
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and treatment. Education regarding disease pathophysiology, medications and how they work, 
treatment options, and a thorough explanation of the risk of stroke is imperative in patients newly 
diagnosed with atrial fibrillation (Borne et al., 2017; Clarkesmith et al., 2013; Kaufman et al., 
2018; Lane, Barker, & Lip, 2015; Lindberg et al., 2017; Madrid et al., 2016; Maikranz et al., 
2017; Thryosee, Stromberg, Brandes, & Hendriks, 2018). Through the provision of reliable 
patient education, the patient experience will be transformed, making patients better equipped to 
make informed decisions about their atrial fibrillation treatment plan.   
 A key element in anticoagulation management is the prevention of stroke. Patients are 
often unaware that atrial fibrillation can lead to ischemic stroke, and may not understand the 
need for anticoagulation to prevent stroke. Throughout the evidence, a strong emphasis was 
present on the need for continuous education for patients who are prescribed anticoagulants for 
atrial fibrillation. Patients often cannot recall education that was discussed at the initial 
consultation regarding anticoagulation indications, monitoring, side effects, and medication 
interactions (Kaufman et al., 2018; Dalmau et al., 2017; Desteghe et al., 2016; Lane et al., 2015; 
Madrid et al., 2016; Maikranz et al., 2017; Desteghe et al., 2018; Pandya & Bajorek, 2016).  
Health Literacy 
 Health literacy can be identified as a primary consideration when providing atrial 
fibrillation patient education. Health literacy is defined as one’s ability to receive, process, and 
understand basic health information and to make an appropriate decision regarding healthcare 
(Aronis et al., 2017). Limited health literacy in patients with atrial fibrillation is linked to poor 
medication adherence, early hospital readmission, and mortality (Aronis et al., 2017; Kaufman et 
al., 2018; Reading et al., 2017).   
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 Lower health literacy is linked with an overall poor understanding of atrial fibrillation, 
including the risk of adverse events such as ischemic stroke. Inadequate health literacy correlates 
to an increase in co-morbid conditions and decrease in self-reported health status. Patients may 
be more likely to engage in negative health behaviors including sedentary lifestyle, poor diet, 
smoking, and medication non-adherence. If a patient does not truly understand the diagnosis, 
treatment, and risks associated with atrial fibrillation, it is likely that they will not adhere to 
treatment plans including anticoagulation therapy or anti-arrhythmic medication (Reading et al., 
2017; Aronis et al., 2017).  
 A strong correlation exists between health literacy, medication adherence, and knowledge 
regarding disease processes and treatment options. Patients with low health literacy are less 
likely to understand why they are taking an anticoagulant, know how it works, and realize the 
possible side effects of the medication. Health literacy and lack of knowledge can cause 
tremendous problems for patients with atrial fibrillation. Low health literacy is associated with 
poor clinical outcomes in most studies, including ischemic stroke and bleeding (Rolls, Obamiro, 
Chalmers, & Bereznicki, 2017; Reading et al., 2017; Aronis et al., 2017).   
 The Agency for Healthcare Research and Quality (AHRQ) has developed a tool for 
healthcare professionals to address health literacy gaps in primary care. This resource, Health 
Literacy Universal Precautions Toolkit, provides an approach to education in the clinical setting 
that affirms patient understanding of information and communication that can be understood by 
all patients, regardless of the level of health literacy. This toolkit has been modified to include 
atrial fibrillation clinical care and practice (Brega et al., 2015). Through the use of the AHRQ 
toolkit, providers can simplify the patient experience and assist patients in achieving an optimal 
level of health. 
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Shared Decision-Making  
Shared decision-making is a vital component in atrial fibrillation care. Current guidelines 
from the American Heart Association, American College of Cardiology, and the Heart Rhythm 
Society recommend a patient-centered approach when choosing anticoagulation (Noseworthy et 
al., 2018). During the shared decision-making process, providers can explore patients’ 
perspectives on atrial fibrillation and treatment options, discuss the options available for 
treatment, verify patient understanding, and create a treatment plan based on the patient’s 
preferences and healthcare needs. Shared decision-making is a multi-dimensional concept, 
including knowledge transfer, agreement on treatment plans, quality of communication, and 
satisfaction with the decision-making process (Pandya & Bajorek, 2016; Dalmau et al., 2017; 
Kunneman et al., 2017).   
Shared decision-making is appropriate for patients with newly diagnosed atrial 
fibrillation due to the many treatment options available. Providers must discuss anticoagulation, 
which includes warfarin and novel oral anticoagulant agents.  Implantable devices such as the 
Watchman implant or Lariat procedure may be determined as a better fit for patients over 
anticoagulation due to individualized risk for bleeding (O’Neill et al., 2017). Patients need to be 
aware of all of the available treatment options for atrial fibrillation, and the use of shared 
decision-making in the clinical setting creates the opportunity for this discussion between the 
patient and provider.  
 To support patients in having meaningful conversations with providers during initial 
consultation, the American College of Cardiology has created a tool called CardioSmart. Patient 
complete this online tool prior to their office visit. The application asks questions about medical 
history, including atrial fibrillation, heart failure, coronary artery disease, age, gender, and renal 
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function. The answers to these questions generate an overall risk category (low, medium, or 
high) for patients who require anticoagulation for atrial fibrillation. An on-screen booklet is 
generated for patients for them to read with detailed education regarding atrial fibrillation and the 
need for anticoagulation. It describes the pathophysiology of the disease, treatment options, and 
calculates a general risk for ischemic stroke. This tool encourages patients to engage in their care 
and facilitates shared decision making with their healthcare provider about anticoagulation 
therapy (American College of Cardiology, 2018).  
 The American Heart Association, American College of Cardiology, and the Heart 
Rhythm Society created a class 1 recommendation for patients and clinicians to work together 
using shared decision-making to create individualized treatment plans for anticoagulant therapy. 
Through the shared decision-making process, patients and providers form a partnership to make 
decisions that are most practical and provides support for the patient. This recommendation 
encourages providers to utilize three key elements in shared decision-making: foster choice 
awareness, introduce options and harms/benefits, and talk through each option and how it would 
fit into the patient’s life (Noseworthy et al., 2018; Pandya & Bajorek, 2016; Siouta et al., 2016). 
Through the implementation of these elements during clinical consultation, patients and 
providers work together to create a personalized treatment plan that allows the patient to be fully 
engaged.   
Theory 
 The theory utilized for the development of this project was the Health Belief Model. This 
model provided a grounded approach that integrates patient decision-making and education in 
newly diagnosed atrial fibrillation. Six constructs comprise the Health Belief Model: perceived 
susceptibility, severity, benefits, barriers, cues to action, and self-efficacy (Bishop et al., 2014).   
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The application of the six constructs of the Health Belief Model in this project led to 
increased patient knowledge and medication adherence after enhanced patient education for 
newly diagnosed atrial fibrillation. The patient’s perceived susceptibility included the 
understanding of individualized risk of ischemic stroke and complications from non-adherence to 
antiarrhythmic and anticoagulant therapies. Perceived severity involved patients being 
introduced to the seriousness of atrial fibrillation and the consequences of poor self-care and lack 
of treatment, including ischemic stroke and death. Perceived benefits through patient education 
included decreased risk of stroke, reduction of symptoms, and enhanced quality of life. Perceived 
barriers may be identified by patients after discussing treatment modalities of atrial fibrillation, 
including risk of bleeding, cardiac dysrhythmia, or complications following cardiac ablation. 
Cues to action and self-efficacy occurred for patients after the intervention (see Appendix D for 
Theory to Application Diagram).  
Methods 
IRB Approval, Site Approval, Ethical Issues, Funding 
 The institutional review board (IRB) for this project was the health system IRB 
associated with the project sites. The IRB reviewed the request, and the project was deemed as 
quality improvement. Therefore, the project did not require IRB approval. The physicians and 
nurse practitioners who worked with potential patients in the study also approved the project. 
One nurse practitioner and three physicians acted as the on-site preceptors to guide the project 
and provided assistance with data collection and analysis.   
 In the selection process of the participants, the project team leader accessed the electronic 
health record of each candidate to determine if the inclusion criteria were met. The information 
that was collected by the researcher included the date of atrial fibrillation diagnosis, age, and 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
14
gender. No protected health information was gathered during the initial data collection phase 
when identifying potential participants. Participants were assigned a numeric code to track the 
completion of the pre and post-tests. No conflicts of interest were identified between the project 
team leader and the collection site. Consent was obtained by the healthcare provider in the office 
visit prior to the intervention.  
 Project funding was obtained from the University of Missouri-Kansas City Women’s 
Council Graduate Assistance Funds. The amount of funding received was $800 through the 
Esther Loeb award. This funding was used to assist with dissemination costs (see Appendix E for 
a detailed cost table). 
Setting and Participants 
The project took place in two cardiovascular specialty clinics located in Kansas City, 
Missouri. Three electrophysiology physicians and five advanced practice providers treated 
patients with atrial fibrillation, along with more than 50 total providers in the practice. 
Participants included male or female patients newly diagnosed with atrial fibrillation in 
the last year age 40 to 75 who possessed a smartphone to download the CardioVisual mobile 
application. Recruited participants were under the direct care of an electrophysiologist with the 
cardiology practice. Exclusion criteria included patients who were diagnosed more than one year 
ago, were younger than 40 and older than 75, or did not have a smartphone or tablet. The sample 
method for this project was convenience sampling to obtain specific data for patients with newly 
diagnosed atrial fibrillation. The expected sample size for this project was 40 participants.  
Intervention 
Patients were recruited from new patient consults and existing patients being seen by 
electrophysiologists at the cardiology clinics. Each patient who met the inclusion criteria was 
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invited to participate in the project. Recruitment took place over three months (see Appendix F 
for a detailed graphic with project timeline flow).  
The intervention consisted of three components: pre-test, educational intervention, and 
post-test at three months. The participant first saw the provider for a scheduled office visit. The 
physician discussed the project at the end of the office visit and obtained verbal consent. Once 
consent was obtained, the participant was taken to a separate exam room to complete the 
intervention. The participant was given the Jessa Atrial Fibrillation Knowledge Questionnaire 
(JAKQ) to complete, as well as the Measurement of Treatment Adherence (MTA) instrument to 
assess anticoagulation adherence. After the questionnaire was complete, the project team leader 
discussed the mobile application and assisted each participant with downloading and registering 
on the application. The project team leader also demonstrated how to use the application, 
including accessing videos and reviewed the process to complete the post-test questionnaires via 
REDCap email. Three months post-intervention, the patient completed both questionnaires a 
second time through a link sent via REDCap email. The project team leader completed data 
analysis through the REDCap system available through the University of Missouri-Kansas City 
(see Appendix G for an intervention flow diagram).  
Change Process and Evidence-Based Practice Model 
The change process theory for this project proposal was Lippitt’s seven-step change 
theory. The steps of this theory include diagnosis of the problem, evaluation of motivation and 
capacity for change, assess resources and motivation, select progressive change objective, choose 
role of change agent, maintain change, and terminate helping relationship (Mitchell, 2013). 
Diagnosis of the problem required the project team leader to develop a detailed plan of proposed 
change. Evaluation of motivation and capacity for change, as well as assessment of resources and 
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motivation were assessed through communication with providers, patients, and organizational 
leaders. The selection of the change objective and the change agent took place in the planning 
stage of the DNP project. The maintenance of change occurred through the implementation of 
the DNP project and continuation of patient education via the CardioVisual mobile application 
following completion of the project. Finally, the termination of the relationship will occur once 
patient education and medication adherence sustained a high level of improvement after project 
implementation. 
The evidence-based practice model that was utilized for this project proposal was the 
Stetler Model of Research Utilization. This model was most appropriate for this project due to 
the practitioner-oriented nature of the model. The assumptions of the Stetler model closely 
aligned with the design of this project. One assumption stated that the formal organization may 
or may not be involved in the utilization of research (Stetler, 2001). In this DNP project, the 
project team leader was not striving to make changes at the organizational level based on project 
results. Instead, the goal of the project was to make improvements in patient education at a more 
focused level in the organization.  
Additionally, five phases were identified in this model: preparation, validation, 
comparative evaluation/decision making, translation and application, and evaluation (Stetler, 
2001). Through the development of this DNP project, these phases were strictly followed. Phase 
one was preparation, through which the practitioner identifies the need to solve a problem. As a 
registered nurse in the electrophysiology clinic, the need was identified for improved patient 
education for atrial fibrillation patients. Phases two and three, validation and comparative 
evaluation, were done through the synthesis of evidence that was recently completed. Phase four, 
translation/application, was completed through the development and implementation of the DNP 
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project. Phase five, evaluation, was achieved through the analysis of data after the completion of 
the project (see Appendix H for a detailed logic model graphic). 
In regard to sustainability following project completion, great potential exists for the 
CardioVisual mobile application to be utilized as an additional source of education for patients. 
The application is free to download and does not require the provider to assist with download. 
The company that developed the application has instructions to register and use the application 
that can be printed for distribution. Free business cards are also available for distribution in the 
cardiovascular office to be given to patients.  
Study Design 
The design for this project was quasi-experimental with one participant group and pre-
test/post-test design. A quasi-experimental design was chosen for this project so that additional 
education would not be withheld from any patient for atrial fibrillation and anticoagulation. This 
design promoted improved outcomes for all participants, rather than just the intervention group 
in a two-group design project, where only one group of participants would receive additional 
education. This allowed for examination of the current educational methods, represented by pre-
test data, and the impact of the CardioVisual mobile application on patient knowledge of atrial 
fibrillation and anticoagulation adherence.  
Validity 
Two primary aspects that promoted the internal validity of the data from this project. The 
first aspect was the short project timeline over three months. The risk of maturation was low over 
the three months for study participants. The second aspect was the study protocol that was 
utilized for the project. The data was uniformly collected from all participants.  
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Two aspects that promoted the external validity of the data. The inclusion and exclusion 
criteria utilized for this study provided a clearly delineated population of focus for the project. 
Additionally, the data supported generalizability of findings to other populations as the 
participants represented a wide variety of participants from various backgrounds and ethnicities. 
This promoted ease of generalizability to other populations, including other outpatient cardiology 
clinics. The intervention is transferable to clinics with patients newly diagnosed with atrial 
fibrillation. 
Outcomes to be Measured 
The primary outcome for the project was increased patient knowledge regarding atrial 
fibrillation. This outcome was evaluated through pre-test and post-test data from the Jessa Atrial 
Fibrillation Knowledge Questionnaire (JAKQ). The secondary outcome was improved adherence 
to anticoagulation therapy over three months.  This was evaluated through the Measurement of 
Treatment Adherence tool (MTA) (Desteghe et al., 2016; Rodrigues da Silva Carvalho et al., 
2010).  
Measurement Instruments 
The JAKQ was a 16-item questionnaire that addressed patient knowledge regarding 
important aspects of atrial fibrillation including atrial fibrillation management and 
anticoagulation therapy. The participants were asked to complete three of four sections on the 
questionnaire. The sections included knowledge about atrial fibrillation, anticoagulants, warfarin 
therapy, and novel oral anticoagulant therapy. If a patient was prescribed warfarin therapy, the 
project team leader selected questions that were directed at warfarin therapy and asked the 
participant to skip the section regarding novel oral anticoagulant therapy. Likewise, if a patient 
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was prescribed novel oral anticoagulant therapy, the project team leader asked the participant to 
skip the section regarding warfarin therapy.  
The construct validity was measured using the Kaiser-Meyer-Olkin measure, which 
revealed an acceptable to good sampling adequacy. The tool had acceptable internal consistency 
with a Cronbach’s alpha level of 0.674 and an acceptable reliability with rs of 0.528 (Desteghe et 
al., 2016). The JAKQ questions and answers were not available in the public domain. The 
project team leader emailed a representative with Hasselt University and completed a user 
agreement to use the JAKQ questionnaire for one year. The JAKQ was an easy-to-complete tool 
used to assess a patient’s knowledge of atrial fibrillation and anticoagulation therapy. The project 
team leader provided a copy of the questionnaire to each participant and asked them to complete 
it prior to providing access to the CardioVisual mobile application.  
 The MTA instrument was structured for self-reporting of medication adherence. Each 
item measured a specific medication-taking behavior. The answer options for the questions were 
on a 6-point Likert scale. A score of 1 correlated with always, 2 with almost always, 3 with 
frequently, 4 with sometimes, 5 with rarely, and 6 with never. No data was available regarding 
MTA instrument validity. Internal consistency was moderate with a Cronbach’s alpha of 0.70 
(Rodrigues da Silva Carvalho et al., 2010). The questions from the MTA instrument were 
available in the public domain. The MTA was administered along with the JAKQ tool. It was 
printed and given to the participants for completion prior to providing access to the CardioVisual 
mobile application.  
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Quality of Data 
A power analysis was conducted using G*Power 3.1 software. The a priori power was 
calculated using a one-tailed t-test. The effect size was 0.5, alpha of 0.05, and power 0.8. The 
total sample size suggested for this project was 34 participants (Faul et al., 2007).  
The measurement of change was based on pre and post-test scores for both the MTA and 
the JAKQ. Participants were assigned a number to identify the pre-test scores and improvement 
after intervention. No protected health information was utilized and the patient’s treatment 
modality was not affected by their scores. The scores were not revealed to providers until after 
data analysis and patient names were not associated with the results. 
Analysis Plan 
Data collection methods also impacted the quality of the data. The project team leader 
was the primary administrator of the pre and post-test questionnaires. Consistency in data 
collection was necessary to maintain high quality data. Providing a quiet environment without 
distraction and ample time to complete the questionnaire was required. Additionally, the tools 
were easily readable by all participants and understandable at a fifth grade reading level.   
The demographics that were collected for this project included age, gender, and date of 
diagnosis of atrial fibrillation. The statistical analyses utilized included independent and paired t-
test to evaluate knowledge and medication adherence pre and post-intervention. Descriptive 
statistics were used to support the project and provide suggestions for project improvement to 
promote future sustainability. No existing studies provided data for comparison to the current 
project. The data collected from this project will be used to develop benchmark data at the clinic 
to continue improvement of patient education in the electrophysiology department and across the 
cardiovascular clinic (see Appendix I for a detailed data collection template).  
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Results 
Setting & Participants 
The project recruitment took place from August 26, 2019 through December 9, 2019. 
Post-testing began December 1, 2019 and was completed March 9, 2020. Participants were 
recruited from patients seeing an electrophysiology at two cardiologist clinics.   
Twenty-eight participants that were recruited and completed pre-testing, and 12 of the 
participants completed post-testing. Of the 28 participants, 21 were male and seven were female. 
The range of participant age was 43 to 74 years. The mean participant age was 61 years. The 
most common anticoagulant therapy among the participants was apixaban for 18 participants, 
followed by rivaroxaban for four participants, warfarin for three participants, dabigatran for one 
participant, and two participants were currently not taking an anticoagulant. 
In regard to time since initial atrial fibrillation diagnosis, 17 patients were diagnosed 9-12 
months prior to the intervention. Additionally, three participants were diagnosed 6-9 months 
prior, six participants were diagnosed 3-6 months prior, and two participants were diagnosed 0-3 
months prior to the intervention.  
Intervention and Actual Course 
 Project recruitment began August 26, 2019 and finished on December 9, 2019. Post-
testing started on December 1, 2019 and ended March 9, 2020. Twenty-eight participants 
completed the pre-tests and downloaded the CardioVisual mobile application. Twelve 
participants completed the online post-tests via an emailed link from REDCap.   
Outcome Data  
 Due to the low response for post-test completion, data analysis was limited to descriptive 
statistics. The primary outcome for this project was increased patient knowledge regarding atrial 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
22
fibrillation. The JAKQ tool was divided into four question categories: general knowledge about 
atrial fibrillation, general knowledge about anticoagulants, knowledge about warfarin therapy, 
and knowledge about novel oral anticoagulant therapy. The overall average score on the JAKQ 
tool increased from 84.9 percent to 87.2 percent on the post-test. General knowledge about atrial 
fibrillation scores also increased from 76 percent to 83 percent. General knowledge about 
anticoagulants increased from 90 percent to 98 percent. Knowledge about warfarin therapy did 
not change with pre- and post-test scores of 100 percent. Knowledge about novel oral 
anticoagulant therapy did not improve on the post-test.  
 The secondary outcome for this project was improved adherence to anticoagulant therapy 
based on MTA scores. The MTA was scored on a six-point Likert scale with a score of 1 
correlating to “always” and 6 correlating to “never.” Scores were analyzed by mean and standard 
deviation on pre- and post-test for each question. Overall adherence to anticoagulant therapy 
increased based on post-test means. The frequency of missed doses due to forgetting to take the 
anticoagulant decreased on post-testing. The mean Likert score for the pre-test was 4.68 and 
1.827 standard deviation. On the post-test, the mean Likert score was 5.63 and 0.505 standard 
deviation. Additionally, fewer patients reported missing anticoagulant doses due to running out 
of the medication. For this question, the pre-test mean was 5.82 and 0.476 standard deviation. 
The post-test mean score was 5.91 with 0.302 standard deviation (see Appendix J for detailed 
statistical analysis results). 
Discussion 
Successes 
 Two main successes were present based on the study outcomes. The increase in patient 
knowledge of atrial fibrillation was the primary success of this project. The results suggested that 
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patient knowledge increased following the use of the CardioVisual mobile application for three 
months. Participants reported that the mobile application was easy to use and provided 
information that could be easily shared with family members.  
 The second success of this project was the improvement in adherence to anticoagulant 
therapy. Based on post-test scores, participants were missing doses of anticoagulant therapy less 
frequently after the intervention. During the intervention, the project team leader emphasized the 
need for adherence to anticoagulant therapy. Informational videos in the mobile application 
provided further information regarding anticoagulant therapy and effects of missed doses 
including elevated risk for ischemic stroke. This improvement has a clinical significant potential 
to lead to positive patient outcomes including stroke risk reduction and quality of life.  
Study Strengths 
 The cardiovascular clinics provided excellent support for the intervention. The patient 
population was advantageous for recruitment. Many patients with atrial fibrillation met the 
inclusion criteria for this project. The clinic staff, including the registered nurses working with 
the physicians, provided support for the project team leader by reminding the physician to 
discuss the project and obtain verbal consent prior to leaving the exam room.  
Additionally, the clinic staff ensured that there was always an exam room or office space 
available to conduct the pre-test and educational intervention. The clinic providers were willing 
to discuss the project with patients who met inclusion criteria. The providers also checked in 
periodically throughout the project timeline to offer advice and assistance. The clinic leadership 
team was available to assist with project  resources and administrative support.  
The intervention was carried out in a semi-successful manner. Participant recruitment 
was completed without major challenges. However, several patients who were identified as 
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potential participants declined participation in the project. In addition, a few patients were not 
comfortable downloading the mobile application or did not have a smartphone. This led to a 
smaller than desired sample size. The pre-test and educational intervention phase were 
successfully completed. Post-testing was completed with complications. Out of 28 participants, 
only 12 participants completed the post-testing phase. A few patients did not provide an accurate 
email address, resulting in a failure to send a message from REDCap. This portion of the 
intervention was the most challenging to navigate due to the nature of the follow-up using email 
only. Participants could not be identified from REDCap, thus those not completing could not be 
emailed for follow-up with the post-test.  
Results Compared to Evidence in the Literature 
 Unfortunately, evidence was not available for atrial fibrillation or heart health mobile 
applications used for patient education. However, there was evidence available for comparison 
for various health topics including depression and schizophrenia. Each of these studies utilized 
mobile applications to provide education to patients.  
 In a 2019 study of a mobile application for depression education and self-management, 
participants reported decreased depression severity with the use of a mobile application. 
Decreased depression severity led to an enhanced quality of life and improved patient outcomes 
(Ventura & Chung, 2019). This study demonstrated the effectiveness of a mobile application for 
patient education and symptom management.   
 In a 2018 pilot study, a mobile application was developed for self-management of 
schizophrenia symptoms. Participants who utilized the mobile application revealed a reduction in 
symptom severity and ability to carry out activities of daily living, as well as an increase in the 
perception of self-efficacy in symptom management (de Almeida et al., 2018). This study 
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demonstrated the effectiveness of education via a mobile application in quality of life for a 
chronic health condition. 
 Although these studies were not directly related to atrial fibrillation, the evidence is 
apparent that education via mobile applications for patients is effective in increasing knowledge, 
reducing symptoms of chronic conditions, improving quality of life. These findings directly align 
with the findings of this evidence-based project. 
Limitations 
Internal Validity Effects 
 One of the possible confounding factors that could have impacted the internal validity of 
this project was through the pre- and post-test method. The questionnaires remained the same for 
the pre- and post-test, which could have led to an increase in scores because participants recalled 
the answers from the pre-test rather than an increase in knowledge as a result of use of the 
mobile application. It is somewhat unlikely due to the three month period between pre-and post-
testing, but should be still be considered. Additionally, a second possible confounding factor is 
the high attrition rate in the sample size. Twenty-eight participants completed the pre-test, but 
only 12 participants completed the post-test. This small number of participants who completed 
the post-test should also be considered when reviewing the project results.  
External Validity Effects 
 Two primary factors should be considered in terms of external validity. The first factor is 
participant demographics. The sample size was comprised of 75 percent males and 25 percent 
females. This percentage does not directly correlate with the general population and could affect 
generalizability of the project results. The second factor that should be considered is the lack of 
demographic data to evaluate the diversity of ethnicities in the sample size. The demographic 
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questionnaire did not examine the ethnic background of participants, which could also affect 
generalizability of project results.  
Sustainability of Effects and Plans to Maintain Effects 
 The outcomes of this evidence-based project were an increase in patient knowledge and 
improved adherence to anticoagulant therapy. As time progresses, there is an expected natural 
weakening of project effects. The project team leader should create a long-term plan to maintain 
the improvements in care in this project. This plan should be created in a collaborative effort 
with providers and healthcare staff in the clinic to promote sustainability of the project.  
It is reasonable to consider extending the use of the mobile application to patients who 
did not participate in the original intervention, as well as patients who were diagnosed with atrial 
fibrillation more than one year ago. Project data revealed that the use of CardioVisual had a 
positive impact on knowledge and anticoagulant adherence. To sustain this effect among all 
patients with newly diagnosed atrial fibrillation, the mobile application should be introduced. 
Education is a key component in chronic disease management and the mobile application 
provides a free, easy to use platform for patients to access at any time. By introducing the mobile 
application to a broader group of patients, the effect of the project will remain and patient 
outcomes will continue to improve.  
Efforts to Minimize Study Limitations 
 Study limitations  should be considered when reviewing the results of this project. Efforts 
were incorporated in the project design to limit the impact of the limitations on application of the 
project results. These efforts included the time frame between the intervention and post-testing, 
the use of email follow-up rather than in office, and the recruitment of patients from two separate 
clinics to promote a broader demographic of participants. 
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 The selection of the three-month time frame between the intervention and post-testing 
was designed to promote use of the mobile application. With a time longer than three months, it 
is likely that participants would not use the application as frequently or stop using it altogether. 
Additionally, the three-month gap between the intervention and post-testing was selected to 
reduce the likelihood of recall of answers from the pre-test which allowed for more reliable post-
test data to be collected. This time frame was successful in minimizing limitations on data from 
the post-test questionnaires.  
 Next, the use of email follow-up was chosen to encourage a decreased attrition rate with 
post-testing. The original design for post-testing was to have patients come into the 
cardiovascular clinic for a nurse only visit with the project team leader to complete the post-test. 
However, this design was noted to have increased potential for attrition due to scheduling 
limitations for patients and project team leader availability. The email follow-up created the 
opportunity for participants to complete the post-test questionnaires at a time that was more 
convenient for them and did not require additional travel to the clinic. Unfortunately, this effort 
was not successful. The attrition rate for this project was higher than expected, with less than 50 
percent of participants completing the post-test questionnaires.  
 Finally, the recruitment of patients from two clinic locations was chosen to create a wider 
demographic of participants. These clinic locations are in two separate parts of the Kansas City 
metro, providing a wider variety of eligible participants to recruit for the project. This effort 
aided in the generalizability of results and stronger external validity. However, the demographics 
of participants were skewed in terms of gender and there was no data collected to support ethnic 
diversity in the sample size.  
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Interpretation 
Expected & Actual Outcome 
 The expected results of the project included an increase in patient knowledge about atrial 
fibrillation and improved adherence to anticoagulant therapy. The outcomes were achieved based 
on data collection and analysis of JAKQ and MTA pre- and post-test scores. Unexpected results 
were identified regarding pre- and post-test scores. It was unexpected that participants would 
score as high on the JAKQ pre-test questionnaire. Participants had a score of 84.9 percent on the 
pre-test. A second unexpected result was the overall mean scores on the pre-test MTA 
instrument. On most questions, participants answered “rarely” or “never” on the Likert scale, 
which translated to a score of 5 or 6. It was anticipated that participants would be less adherent to 
anticoagulant therapy. However, these results indicated an excellent level of patient education 
provided by the healthcare team at the clinic at time of atrial fibrillation diagnosis. 
 Two problems occurred during the project. The first problem was the small sample size 
after three months of recruitment. More than 40 eligible participants were identified by the 
project team leader. However, the provider and nurse working with the provider in the clinic 
often forgot to discuss the project and obtain consent from the patient prior to leaving the exam 
room. The provider was seeing 20 patients each day in the clinic and was often short on time. It 
was also noted that the providers have several years of experience with a set routine for office 
visits and time length, leading to omission of the project content and obtaining consent before 
leaving the exam room.  
 The second problem that occurred during the project was the large number of participants 
who did not complete the post-test questionnaires. Each participant received an email reminder 
for three consecutive days if the questionnaires were not completed. The lack of follow-up could 
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be attributed to technological causes. The emails from REDCap could have been delivered to the 
participant’s junk email folder. It is also possible that the participant did not provide an email 
address that is checked regularly. This problem led to results that could not be analyzed using 
inferential statistics as initially planned.   
Intervention Effectiveness 
 Overall, the intervention was effective in achieving the primary and secondary outcomes. 
Three causal mechanisms were identified that contributed to the effectiveness of this project. 
One causal mechanism was the design of the intervention. The project design was structured in a 
relatively simple manner with one cohort of participants. The mobile application was easy to use 
for participants and did not require significant technical skill. By avoiding a complex 
intervention, the project was successful.  
A second causal mechanism was the support from providers and clinic staff during the 
recruitment phase. The physicians were essential to recruitment for the project. If the providers 
were not supportive, the sample size would have likely been much smaller. The clinic staff also 
played a key role in this phase by ensuring an exam room was available for the intervention and 
assisting with patient navigation during project recruitment. A third causal mechanism was the 
project setting. The project team leader was a member of the healthcare team in the clinic where 
the project took place. By having an existing relationship with providers and staff, the project 
team leader was able to carry out the intervention effectively.  
This study intervention is most likely to be effective in cardiovascular clinics in suburban 
or metropolitan areas. This closely aligns with the setting in which the intervention took place. In 
rural settings, participants may not be as likely to have a smartphone to download the mobile 
application. Additionally, specialty clinic providers often have more time to spend with patients 
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during each office visit to discuss the plan of care and to introduce educational resources 
including mobile technology. A cardiology or specialty setting would be the most likely to 
replicate this study intervention with success.  
Intervention Revision 
 Three primary revisions to the intervention could improve attainment of the project 
outcomes. The first modification would be to expand recruitment to participants who were 
diagnosed with atrial fibrillation more than one year ago. A large portion of patients seeing the 
electrophysiology clinicians for atrial fibrillation were diagnosed more than one year ago. 
Patients are not being seen at the time of initial diagnosis as general cardiologists can manage the 
condition with medications. Patients are often referred from general cardiology providers for 
atrial fibrillation when they require advanced anti-arrhythmic therapy or cardiac ablation to treat 
atrial fibrillation. Patient education could be beneficial for patients with atrial fibrillation at any 
time, not just at time of diagnosis.  
 The second modification for this project would be to create a more detailed follow-up for 
post-testing. Emailing participants with the survey link from REDCap was not successful in this 
project and led to a large number of participants not completing the post-test questionnaires. It 
would be beneficial to have additional contact with participants during the post-test phase. A 
phone call to participants to confirm that the survey was received, as well as a reminder phone 
call to participants who did not complete the post-test questionnaires could lead to reduced 
attrition rates.  
 Finally, the third modification for this project would be to utilize the follow-up 
modification above and assign a number to each participant. The project team leader could then 
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track pre- and post-test scores for each participant, allowing for paired t-test analysis of results, 
which would yield statistically significant data and more impactful results.  
Expected and Actual Impact to Health Systems, Costs, and Policy 
 The expected impact of this intervention on the health system was to decrease stroke risk 
reduction in participants and increase patient ability to participate in shared decision-making. 
The expected impact on policy was to expand patient education to mobile applications, instead of 
focusing on printed handouts. The expected impact of this project on cost was to decrease 
hospitalizations due to complications from missed doses of anticoagulant therapy, including 
ischemic stroke.  
 The cost of the project was free, except for time investment of project team leader and 
providers involved with the participants. The estimated cost for dissemination of results at two 
area conferences was $800. Funding was secured to attend both of these conferences. The 
funding source was secured through the University of Missouri-Kansas City graduate assistance 
fund and was used for dissemination purposes only. The mobile application was free to 
download and additional resources were provided by the clinic locations.  
The potential for economic sustainability is extremely high. The mobile application is 
free to download and use, yielding no cost to patients or providers. This is highly beneficial for 
patients and will provide excellent opportunities to increase patient knowledge and improve 
patient adherence to anticoagulant therapy in the future.  
Conclusions 
Practical Usefulness of Intervention 
 This evidence-based practice intervention presented the opportunity to improve patient 
knowledge, medication adherence, and overall patient outcomes for patients. The intervention 
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allowed for improvement in shared decision-making based on an increase in patient knowledge. 
The CardioVisual mobile application offers a wide variety of videos about cardiac conditions 
including heart disease, myocardial infarction, and heart failure. This project could potentially be 
replicated in other areas in the cardiology practice, including structural and general cardiology. 
Further Study or Implementation of Intervention 
 This project could be expanded and modified to provide education to patients across all 
areas of practice at the cardiology clinic, including structural and general cardiology. Further 
study for this project could include evaluation of patient satisfaction before and after the project 
is complete to see if the intervention increased patient satisfaction scores, as suggested by 
another provider at the cardiology clinic. Additionally, the project could expand to examine the 
differences in patient knowledge and adherence across other cardiology clinic locations and rural 
practice locations. 
Dissemination 
 The dissemination plans for this project included submission of the project and results to 
the Journal of Doctoral Nursing Practice.  The project results and data were made available for 
viewing at the project site. It was also presented to the electrophysiology department at the 
monthly staff meeting and provider meeting. Additionally, the project team leader presented the 
project proposal through a poster presentation at the Advanced Practice Nurses of the Ozarks 
annual conference in November 2019 and the project with results at the Midwest Nursing 
Research Society annual conference via online poster presentation in April 2020.  
 
 
 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
33
References 
Almeida, R., Couto, A., Marques, A., Queiros, C., & Martins, C. (2018). Mobile application for 
self-management in schizophrenia: A pilot study. Journal of Technology in Human 
Services, 36(4). https://doi.org/10.1080/15228835.2018.1483859 
American College of Cardiology. (2018). Afib Decision Aid for Anticoagulation for Non-
Valvular AFib. https://www.acc.org/tools-and-practice-support/quality-
programs/anticoagulation-initiative/anticoagulation-shared-decision-making-tool 
American Heart Association. (2016a). Treatment guidelines of atrial fibrillation (AFib or AF). 
https://www.heart.org/en/health-topics/atrial-fibrillation/treatment-and-prevention-of-
atrial-fibrillation/treatment-guidelines-of-atrial-fibrillation-afib-or-af 
American Heart Association. (2016b). What is Atrial Fibrillation (AFib or AF)? 
https://www.heart.org/en/health-topics/atrial-fibrillation/what-is-atrial-fibrillation-afib-or-
af 
American Stroke Association. (2016). Ischemic Stroke (Clots). 
https://www.strokeassociation.org/en/about-stroke/types-of-stroke/ischemic-stroke-clots 
Aronis, K., Edgar, B., Lin, W., Martins, M. A. P., Paasche-Orlow, M., & Magnani, J. (2017). 
Health literacy and atrial fibrillation: Relevance and future directions for patient-centered 
care. European Cardiology Review, 12(1). https://doi.org/10.15420/ecr.2017:2:2 
Bishop, A., Baker, G. R., Boyle, T., & MacKinnon, N. (2014). Using the health belief model to 
explain patient involvement in patient safety. Health Expectations, 18. 
https://doi.org/10.1111/hex.12286 
Borne, R., O’Donnell, C., Turakhia, M., Varosy, P., Jackevicius, C., Marzec, L., Masoudi, F., 
Hess, P., Maddox, T., & Ho, P. M. (2017). Adherence and outcomes to direct oral 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
34
anticoagulants among patients with atrial fibrillation: Findings from the veterans health 
administration. BMC Cardiovascular Disorders, 17(236). https://doi.org/10.1186/s12872-
017-0671-6 
Brega, A., Barnard, J., Mabachi, N., Weiss, B., DeWalt, D., Brach, C., Cifuentes, M., Albright, 
K., & West, D. (2015). AHRQ Health Literacy Universal Precautions Toolkit, Second 
Edition. https://www.ahrq.gov/sites/default/files/publications/files/healthlittoolkit2_4.pdf 
Clarkesmith, D., Lip, G., & Lane, D. (2017). Patients’ experiences of atrial fibrillation and non-
vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A 
qualitative study. Thrombosis Research, 153. 
https://doi.org/10.1016/j.thromres.2017.03.002 
Clarkesmith, D., Pattison, H., Lip, G., & Lane, D. (2013). Educational intervention improves 
anticoagulation control in atrial fibrillation patients: The TREAT randomised trial. PLoS 
ONE, 8(9). https://doi.org/10.1371/journal.pone.0074037 
Desteghe, L., Engelhard, L., Raymaekers, Z., Kluts, K., Vijgen, J., Dilling-Boer, D., Koopman, 
P., Schurmans, J., Dendale, P., & Heidbuchel, H. (2016). Knowledge gaps in patients 
with atrial fibrillation revealed by a new validated knowledge questionnaire. 
International Journal of Cardiology, 223. https://doi.org/10.1016/j.ijcard.2016.08.303 
Desteghe, L., Germeys, J., Vijgen, J., Koopman, P., Dilling-Boer, D., Schurmans, J., Delesie, M., 
Dendale, P., & Heidbuchel, H. (2018). Effectiveness and usability of an online tailored 
education platform for atrial fibrillation patients undergoing a direct current cardioversion 
or pulmonary vein isolation. International Journal of Cardiology, 272. 
https://doi.org/10.1016/jijcard.2018.07.065 
Faul, F., Erdfelder, E., Lang, A., & Buchner, A. (2007). G*Power 3: A flexible statistical power 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
35
analysis program for the social, behavioral, and biomedical sciences. Behavioral 
Research methods. 
Guo, Y., Chen, Y., Lane, D., Liu, L., Wang, Y., & Lip, G. (2017). Mobile Health Technology for 
Atrial Fibrillation Management Integrating Decision Support, Education, and Patient 
Involvement: mAF App Trial. The American Journal of Medicine, 130. 
https://doi.org/10.1016/j.amjmed.2017.07.003 
Kaufman, B., Kim, S., Pieper, K., Allen, L., Gersh, B., Naccarelli, G., Ezekowitz, M., Fonarow, 
G., Mahaffey, K., Singer, D., Chan, P., Freeman, J., Ansell, J., Kowey, P., Rieffel, J., 
Piccini, J., Peterson, E., & O’Brien, E. (2018). Disease understanding in patients newly 
diagnosed with atrial fibrillation. Heart Journal, 1. https://doi.org/10.1136/heartjnl-2017-
312124 
KC HealthMatters. (2019). Summary Data for Zip Code: 64111. 
https://kchealthmatters.org/demographics-dashboard 
McCabe, P., Rhudy, L., & DeVon, H. (2014). Patients’ experiences from symptom onset to 
initial treatment for atrial fibrillation. Journal of Clinical Nursing, 24. 
https://doi.org/10.1111/jocn.12708 
Melnyk, B. M., & Fineout-Overholt, E. (2019). Evidence-based practice in nursing and 
healthcare: A guide to best practice (4th ed.). Wolters Kluwer. 
Missouri Department of Health & Senior Services. (2017). Risk factors and prevalence rates for 
stroke among adults 18 years and older in Jackson County. 
https://webapp01.dhss.mo.gov/MOPHIMS/ProfileBuilder?pc=9 
Mitchell, G. (2013). Selecting the best theory to implement planned change. Art & Science: 
Nursing Management, 20(1). 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
36
http://content.ebscohost.com/ContentServer.asp?EbscoContent=dGJyMMTo50SeqLc4y9
fwOLCmr1GeqLBSsqe4SLKWxWXS&ContentCustomer=dGJyMK6ttkW2qK5T69fnhr
nt8Xnu3wAA&T=P&P=AN&S=R&D=buh&K=86746704 
Noseworthy, P., Brito, J., Kunneman, M., Hargraves, I., Zeballos-Palacios, C., Montori, V., & 
Ting, H. (2018). Shared decision-making in atrial fibrillation: navigating complex issues 
in partnership with the patient. Journal of Interventional Cardiac Electrophysiology. 
https://doi.org/10.1007/s10840-018-0465-5 
Okello, S., Nasasira, B., Ndichu Wa Muiru, A., & Muyingo, A. (2016). Validity and reliability of 
a self-reported measure of antihypertensive medication adherence in Uganda. PLoS ONE, 
11(7). https://doi.org/10.1371/journal.sone.0158499 
O’Neill, E., Grande, S., Sherman, A., Elwyn, G., & Coylewright, M. (2017). Availability of 
patient decision aids for stroke prevention in atrial fibrillation: A systematic review. 
American Heart Journal, 191. https://doi.org/10.1016/j.ahj.2017.05.014 
Pandya, E., & Bajorek, B. V. (2016). Assessment of Web-based education resources informing 
patients about stroke prevention in atrial fibrillation. Journal of Clinical Pharmacy and 
Therapeutics, 41. https://doi.org/10.1111/jcpt.12446 
Reading, S., Go, A., Fang, M., Singer, D., Liu, I.-L. A., Black, M. H., Udaltsova, N., & 
Reynolds, K. (2017). Health literacy and awareness of atrial fibrillation. Journal of the 
American Heart Association, 6. https://doi.org/10.1161/JAHA.116.005128 
Rodrigues da Silva Carvalho, A., Aparecida Spadoti Dantas, R., Martinelli Pelegrino, F., & 
Scalone Almeida Corbi, I. (2010). Adaptation and Validation of an Oral Anticoagulation 
Measurement of Treatment Adherence Instrument. Revista Latino-Americana de 
Enfermagem, 18(3). https://doi.org/10.1590/S0104-11692010000300002 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
37
Rolls, C., Obamiro, K., Chalmers, L., & Bereznicki, L. (2017). The relationship between 
knowledge, health literacy, and adherence among patients taking oral anticoagulants for 
stroke thromboprophylaxis in atrial fibrillation. Cardiovascular Therapeutics, 35. 
https://doi.org/10.1111/1755-5922.12304 
Salmasi, S., Kwan, L., MacGillivay, J., Bansback, N., De Vera, M., Barry, A., Harrison, M., 
Andrade, J., Lynd, L., & Loewen, P. (2018). Assessment of atrial fibrillation patients’ 
education needs from patient and clinician perspectives: A qualitative descriptive study. 
Thrombosis Research, 173. https://doi.org/10.1016/j.thromres.2018.11.015 
Sankaranarayanan, R., Kirkwood, G., Visweswariah, R., & Fox, D. (2015). How does chronic 
atrial fibrillation influence mortality in the modern treatment era? Current Cardiology 
Reviews, 11(3). https://doi.org/10.2174/1573403X10666140902143020 
Stetler, C. (2001). Updating the Stetler model of research utilization to facilitate evidence-based 
practice. Nursing Outlook, 49(6). https://doi.org/10:1067/mno.2001.120517 
Thryosee, L., Stromberg, A., Brandes, A., & Hendriks, J. (2018). Management of newly 
diagnosed atrial fibrillation in an outpatient clinic setting- patient’s perspectives and 
experiences. Journal of Clinical Nursing, 27. https://doi.org/10.1111/jocn.13951 
Ventura, J., & Chung, J. (2019). The lighten your life program: An educational support group 
intervention that used a mobile app for managing depressive symptoms and chronic pain. 
Journal of Psychosocial Nursing & Mental Health Services, 57(7). 
https://doi.org/10.3928/02793695-20190221-01 
 
 
 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
38
Appendix A: Definition of Terms 
Atrial fibrillation: A cardiac arrhythmia in which the atria of the heart beat irregularly and fail to 
move blood adequately to the ventricles (American Heart Association, 2016b).  
 
Anticoagulant therapy: Utilized to reduce risk of ischemic stroke. Medications commonly used 
include warfarin which is known as a vitamin K antagonist, or direct-acting oral anticoagulants 
which include dabigatran, apixaban, rivaroxaban, or edoxaban (American Heart Association, 
2016a).  
 
Ischemic stroke: Occurs when a vessel supplying blood to the brain becomes obstructed 
(American Stroke Association, 2016).  
 
CardioVisual mobile application: A free mobile application developed by cardiologists that is 
available on iOS or Android; provides educational information regarding a host of cardiac 
conditions including atrial fibrillation.  
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Appendix B: Evidence Table  
In patients age 40-75 with newly diagnosed atrial fibrillation within the last year, does education 
provided via the CardioVisual mobile app, compared to current education provided by Heart 
Rhythm Society brochures, increase patient knowledge of atrial fibrillation and improve 
anticoagulation adherence in three months at a cardiology clinic? 
First author, 
Year, Title, 
Journal 
Purpose Research Design1, 
Evidence Level2 & 
Variables 
Sample & 
Sampling, 
Setting 
Measures 
& 
Reliability 
(if 
reported) 
Results & 
Analysis Used 
Limitations 
& 
Usefulness 
Desteghe 
(2018). 
Effectiveness 
and usability 
of an online 
tailored 
education 
platform for 
atrial 
fibrillation 
patients 
undergoing a 
direct current 
cardioversion 
or pulmonary 
vein isolation. 
International 
Journal of 
Cardiology. 
Evaluate 
effectivene
ss of 
online 
tailored 
education 
platform 
for AF 
patients.  
Quantitative study, 
Level II evidence. 
Variables: Online 
tailored education, 
standard education 
with online access, 
and standard care 
without access to 
computer/tablet/sm
artphone.  
120 patients 
included in 
study. 
Convenienc
e sampling 
at Belgian 
tertiary care 
hospital.  
Knowledg
e evaluated 
with 16 
item 
JAKQ. 
Reliability 
data not 
available.  
 
Quality of 
life 
assessed 
using AF 
Effect on 
Quality of 
line 
(AFEQT) 
questionna
ire. 
Previous 
validation- 
Internal 
consistenc
y (>0.88 
for all 
domains).  
Tailored online 
education 
effective in 
improving AF 
and procedure 
related 
knowledge. 
Long-lasting 
knowledge up 
to 12-weeks 
post-
procedure. 
Most patients 
indicated 
online 
platform was 
preferred 
method of 
receiving 
education 
about AF in 
the future.  
Procedure-
related 
questions 
did not 
undergo 
extensive 
validation. 
Patients 
without 
smartphone/
tablet 
completed 
questionnair
es at 
hospital 
only. 
Patients 
could use 
Google to 
find 
answers.  
Kaufman 
(2018). 
Disease 
understanding 
in patients 
newly 
diagnosed 
with atrial 
fibrillation. 
Heart 
Journal.   
Evaluate 
survey data 
from 
SATELLI
TE sub-
study to 
determine 
relationshi
p between 
patient 
understand
ing of 
therapies 
and how 
disease 
understand
ing 
Quantitative study, 
Level III evidence. 
Variables: patient 
understanding of 
AF disease 
concepts, stroke 
risk understanding 
at baseline and 6 
months.  
1004 
participants 
selected 
from 
SATELLIT
E sub-study. 
Convenienc
e sampling 
from 
cardiology, 
electrophysi
ology, and 
primary care 
participants.   
Survey 
questions 
developed 
and refined 
by 
cardiology 
research 
panel. 
Validity 
confirmed 
by ORBIT-
AF study 
investigato
rs. 
No 
reliability 
data given.  
Among new-
onset AF 
patients, most 
were not 
confident in 
their 
understanding 
of rhythm 
control, 
ablation, 
anticoagulatio
n, and 
cardioversion. 
13% of 
patients did 
not know 
stroke risk was 
Limited to 
small 
number of 
sites and 
small 
sample size. 
Interpret 
self-
reported 
data with 
caution.  
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changes 
over the 
first six 
month of 
diagnosis.  
 
  
associated with 
AF. 
Anticoagulatio
n knowledge 
increased at 6-
month re-
evaluation.  
Salmasi 
(2018). 
Assessment 
of atrial 
fibrillation 
patients’ 
education 
needs from 
patient and 
clinician 
perspectives: 
A qualitative 
descriptive 
study. 
Thrombosis 
Research. 
Gather 
insight into 
atrial 
fibrillation 
patient 
educationa
l needs 
from 
patient and 
clinician 
viewpoints
.  
Qualitative, level 
VI evidence, single 
descriptive study. 
Variables: 
responses to 
interview 
questions.  
21 
participants 
(patients, 
pharmacists, 
NPs, RNs, 
and MD) 
were 
interviewed. 
Purposive 
sampling.  
Interviews 
were 
recorded 
and field 
notes 
taken; 
transcripts 
generated 
and themes 
were 
identified.  
 
No 
reliability 
data 
available. 
Important to 
identify 
emotional 
education 
needs among 
AF patients. 
Education 
should address 
clinical 
information 
and patient 
anxiety.  
Patients 
may have 
different 
preferences 
on 
education 
types based 
on past 
experience 
with 
education.  
 
Newly 
diagnosed 
patients 
likely have 
more 
knowledge 
gaps and 
needs.  
Borne (2017). 
Adherence 
and outcomes 
to direct oral 
anticoagulant
s among 
patients with 
atrial 
fibrillation: 
Findings from 
the veterans 
health 
administratio
n. BMC 
Cardiovascul
ar Disorders.  
Evaluate 
medication 
adherence 
to 
anticoagul
ants and 
association 
between 
adherence 
and patient 
outcomes.  
Quantitative, Level 
IV, retrospective 
cohort study. 
Measured 
adherence to 
anticoagulation 
through number of 
days covered. All 
cause mortality and 
stroke analyzed via 
databases.   
2882 
patients in 
analysis. 
Purposive 
sampling 
utilized. 
Took place 
in the VA 
Healthcare 
System 
Number of 
days 
covered 
measured 
by number 
of doses 
dispensed 
over 
certain 
time 
period. 
Adherence 
= PDC > 
80%. All 
cause-
mortality 
and stroke 
obtained 
through 
VA Vital 
Status File 
and Social 
Security 
Administra
tion Death 
Files. 
 
25% 
suboptimal 
adherence on 
all 
anticoagulants.  
Analyzed with 
network 
algorithm of 
Mehta and 
Patel.  
 
Older age, 
diabetes, and 
stroke 
contribute to 
higher risk of 
stroke.  
 
Non-adherence 
associated with 
mortality and 
stroke, 
especially with 
pradaxa and 
xarelto. 
Analyzed via 
GEE logistic 
regression.  
One 
healthcare 
system. 
Mostly 
white male 
patients. 
Lack of 
distinction 
between 
dispensing 
and 
consumptio
n of 
medications
. Smaller 
number of 
patients on 
eliquis and 
xarelto.  
Useful to 
examine 
anticoagula
nt 
adherence 
patterns of 
patients 
with atrial 
fibrillation.  
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No 
reliability 
data given.  
Clarkesmith 
(2017). 
Patients’ 
experiences 
of atrial 
fibrillation 
and non-
vitamin K 
antagonist 
oral 
anticoagulant
s (NOACs) 
and their 
educational 
needs: A 
qualitative 
study. 
Thrombosis 
Research.  
Provide 
further 
evidence 
regarding 
patient 
perception
s, 
experience
s, and 
understand
ing of 
NOACs. 
Give 
insight into 
educationa
l needs of 
patients 
with AF 
taking 
dabigatran.  
Qualitative study, 
level VI evidence.  
Variables: 
educational needs 
of patients taking 
NOACs. Patient’s 
experiences, 
perceptions of AF, 
warfarin, and 
NOACs. Patients 
interviewed by 
researcher.  
Sample size 
16. 8 
patients in 
warfarin-
naïve group 
and 8 
patients in 
warfarin-
experienced 
group.  
Purposive 
sampling 
utilized. 
Took place 
at AF 
outpatient 
clinic in 
Birmingham
.  
Themes 
and sub-
themes 
were 
derived 
from 
transcriptio
n of patient 
interviews. 
 
No 
reliability 
data given.   
6 main themes: 
Understanding 
the diagnosis, 
reaching a 
treatment 
decision, 
challenges of 
living with 
anticoagulatio
n, patient 
perceptions of 
treatment, 
challenges of 
living with AF, 
and patient 
recommendati
ons.  
Deductive 
thematic 
analysis- 
risk that 
insights 
may be 
missed by 
trying to fit 
into existing 
themes.  
Generalizab
ility limited 
as study 
focused on 
dabigatran 
in one 
setting. 
 
Easily 
replicated.  
Dalmau 
(2017). 
Patients’ and 
physicians’ 
perceptions 
and attitudes 
about oral 
anticoagulatio
n and atrial 
fibrillation: A 
qualitative 
systematic 
review. BMC 
Family 
Practice.  
Synthesis 
of 
evidence 
regarding 
qualitative 
and mixed 
methods 
evidence to 
determine 
patient and 
physician 
attitudes 
toward 
warfarin to 
explore 
factors 
related to 
underuse.  
Qualitative 
systematic review, 
Level V evidence. 
PubMed, 
EMBASE, ISIS 
WoK, and 
PsycINFO. 
Keywords: values 
or preferences, 
anticoagulants, and 
atrial fibrillation.  
9 studies 
included in 
review. 
Purposive 
sampling.  
Critical 
appraisal 
done using 
Critical 
Appraisal 
Skills 
Programm
e tool for 
qualitative 
studies.  
Three themes: 
information to 
reinforce 
anticoagulant 
use, balance of 
benefits and 
downsides, & 
roles in 
decision-
making and 
therapy 
management.   
Cannot 
confirm 
relationship 
between 
factors 
identified 
and 
underuse of 
warfarin. 2 
studies that 
included 
other 
healthcare 
providers as 
participants. 
CINAHL 
results not 
included.  
Maikranz 
(2017). Does 
a complex 
intervention 
increase 
patient 
knowledge 
about oral 
anticoagulatio
n? A cluster-
randomized 
controlled 
trial. BMC 
Family 
Practice. 
Evaluate 
an 
interventio
n including 
practice-
based 
anticoagul
ation 
manageme
nt and 
patient 
education 
improved 
knowledge 
about 
Quantitative, level 
II evidence, 
randomized control 
trial. Variables: 
patient knowledge 
at baseline, 12, and 
24 months. Control 
group received 
usual treatment and 
intervention group 
received practice-
based case 
management and 
patient education. 
736 
participants, 
Convenienc
e sampling 
among 52 
general 
practices in 
Germany.  
Knowledg
e 
assessment 
developed 
in previous 
trial for 
anticoagul
ation 
therapy 
education.  
 
No 
reliability 
data given.  
Patients are at 
high risk for 
poor 
anticoagulatio
n control 
without 
standardized 
patient 
education 
strategies.  
 
There is a need 
for follow-up 
education and 
self-
Selection 
bias, loss to 
follow up at 
the 24-
month 
mark, and 
use of 
questionnair
e that was 
used for 
warfarin 
patients 
only in the 
previous 
study. 
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anticoagul
ation 
therapy.  
management 
strategies for 
patients. 
 
Analysis: 
means/standar
d deviation of 
scores at 
baseline and 
follow-ups.   
 
This study 
could easily 
be 
replicated in 
any clinic 
setting.  
Lindberg 
(2017). Older 
individuals’ 
need for 
knowledge 
and follow-up 
about their 
chronic atrial 
fibrillation, 
lifelong 
medical 
treatment and 
medical 
controls. 
Scandinavian 
Journal of 
Caring 
Sciences. 
Explore 
and 
describe 
lifelong 
medical 
treatment 
from 
perspective 
of older 
patients 
living with 
chronic 
AF.  
Qualitative, level 
VI evidence, single 
descriptive study. 
Variables: patient 
responses to 
interview 
questions.  
11 
participants 
from one 
medical 
center in 
Sweden, 
convenience 
purposive 
sampling.  
Interview 
conducted 
by 
researchers
. Thematic 
analysis 
was 
conducted. 
 
No 
reliability 
data 
available.  
Need for 
knowledge in 
older 
individuals 
living with 
chronic AF.  
 
Need for 
follow-up in 
older people 
living with 
chronic AF.  
Small 
number of 
participants. 
Single 
center 
study. 
 
Could be 
replicated at 
other 
facilities.  
Thryosee 
(2017). 
Management 
of newly 
diagnosed 
atrial 
fibrillation in 
an outpatient 
clinic setting- 
patient’s 
perspectives 
and 
experiences. 
Journal of 
Clinical 
Nursing. 
Describe 
newly 
referred 
AF 
patients’ 
experience
s of 
consultatio
ns at an AF 
clinic.  
Qualitative, level 
VI evidence, single 
descriptive study. 
Variables: 
researcher field 
notes and patient 
experiences from 
post-appointment 
interview.   
14 
participants 
from one 
cardiology 
practice. 
Convenienc
e purposive 
sampling. 
Researcher 
collected 
field notes 
during 
consultatio
n and 
performed 
an 
interview 
after the 
consultatio
n.  
 
No 
reliability 
data 
available 
for 
interview 
questions.  
Extensive 
disease and 
treatment 
information 
during 
consultation 
creates 
confusion for 
patients and is 
overwhelming.  
 
No analysis 
data available.  
Single-
center 
study, small 
number of 
healthcare 
providers 
involved.  
 
Fieldwork 
with 
presence of 
researcher 
could have 
influenced 
provider 
behaviors 
during the 
office visit.  
 
Small 
number of 
participants.  
 
Could be 
replicated at 
other 
clinics.  
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Madrid 
(2016). 
Differences in 
attitude, 
education, 
and 
knowledge 
about oral 
anticoagulatio
n therapy 
among 
patients with 
atrial 
fibrillation in 
Europe: result 
of a self-
assessment 
patient survey 
conducted by 
the European 
Heart Rhythm 
Association. 
Europace.  
Analysis of 
self-
reported 
patient 
knowledge 
and 
attitude 
regarding 
blood 
thinners in 
patients 
with AF. 
Quantitative, level 
III evidence, single 
quantitative study. 
Variable: Patient 
knowledge.  
1147 
participants 
completed 
survey. 
Convenienc
e sampling 
from 
patients who 
are seen by 
providers in 
the EP 
Research 
Network 
centers.  
Questionna
ire 
developed 
by 
members 
of the 
EHRA 
committee. 
Created in 
an 
electronic 
online 
platform.  
 
No 
reliability 
data given.  
Significant 
number of 
patients who 
do not 
understand the 
purpose of 
anticoagulatio
n. Most 
patients did 
not know was 
NOACs were 
for and 
thought that 
warfarin was 
self-managed. 
 
Education 
regarding 
anticoagulatio
n in patients 
with AF is key 
to disease 
management.  
 
Analysis: 
Fisher’s exact 
test, Mann-
Whitney U 
test. Shapiro-
Wilk test.  
Differences 
in 
educational 
level may 
compromise 
results of 
survey.  
Lane (2015). 
Best practice 
for atrial 
fibrillation 
patient 
education. 
Current 
pharmaceutic
al design. 
Summarize 
available 
literature 
about AF 
patient 
knowledge 
regarding 
disease and 
manageme
nt.  
Qualitative study, 
level V evidence, 
review of literature.  
No 
information 
available 
regarding 
number of 
studies 
reviewed or 
the search 
engines/key
words that 
were used.  
No 
informatio
n given.  
Main themes 
from patient 
experiences:  
-finding 
meaning of 
symptoms, 
feeling 
uninformed 
and 
unsupported, 
turning points, 
trying to steer 
clear of AF, 
managing 
unpredictable 
and function-
limiting 
symptoms, 
emotional 
distress, and 
accommodatio
n tempered 
with a hope for 
cure.  
 
No 
limitations 
were 
explicitly 
provided by 
authors.  
 
Information 
regarding 
literature 
search not 
provided.  
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Educational 
topics for 
patients with 
AF: atrial 
fibrillation and 
associated 
risks, basics of 
anticoagulatio
n, risks and 
benefits of 
anticoagulatio
n, 
anticoagulatio
n treatment 
options, 
medication 
adherence, 
monitoring of 
OAC control, 
medication 
interactions, 
lifestyle 
modification, 
accessing 
healthcare 
professionals, 
self-care, and 
self-
monitoring.  
 
 
 
 
McCabe 
(2014). 
Patients’ 
experiences 
from 
symptom 
onset to 
initial 
treatment for 
atrial 
fibrillation. 
Journal of 
Clinical 
Nursing.  
Evaluate 
patient 
experience
s from 
onset to 
initial 
treatment 
for AF via 
open-
ended 
questionna
ire.  
Qualitative, level 
VI evidence, single 
qualitative study. 
Variables: Patient 
experiences via 
open-ended 
questions.  
41 
participants. 
Convenienc
e purposive 
sampling 
from 
progressive 
care 
telemetry 
units at an 
academic 
medical 
center in the 
Midwestern 
US.  
Open 
ended 
questions 
were 
developed 
by the 
study 
coordinato
r. No 
reliability 
data is 
available.  
Main themes: 
Misinterpretin
g symptoms, 
discovering the 
meaning of 
AF, facing 
fears and 
uncertainty/mo
ving to 
acceptance, 
receiving 
validation and 
reassurance. 
 
Data analysis: 
audio 
recordings 
transcribed 
from each 
interview. 
Transcripts 
were coded to 
Patient 
interviews 
are subject 
to self-
interpretatio
n of 
questions. 
Lack of 
ethnic and 
cultural 
diversity 
among 
participants.  
 
This study 
provides 
support for 
the topics 
that are 
most 
meaningful 
for patients 
newly 
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identify 
themes.  
diagnosed 
with AF. 
The study 
could be 
easily 
replicated at 
another 
hospital or 
clinic 
setting.  
Clarkesmith 
(2013). 
Educational 
intervention 
improves 
anticoagulatio
n control in 
atrial 
fibrillation 
patients: The 
TREAT 
randomised 
trial. PLOS 
ONE.  
Determine 
impact of 
education 
on time in 
therapeutic 
and patient 
knowledge 
for patients 
taking 
warfarin.  
Quantitative, 
experimental. 
Level II, 
Randomized 
control trial. If 
patients provided 
with education, 
then time spent 
within therapeutic 
INR range will 
increase. 
Secondary 
outcomes- patient 
knowledge, illness 
perception, 
medication beliefs, 
and quality of life 
improve/increase. 
97 patients 
(46 in 
intervention 
and 51 in 
control). 
Convenienc
e sampling 
of patients 
at AF clinic. 
Took place 
at specialist 
AF clinics 
and 
anticoagulat
ion 
outpatient 
clinics.  
INR/time 
in 
therapeutic 
range 
determined 
through 
INR data 
from 
months 1-
12.  
 
Secondary: 
Beliefs 
about 
medication 
scale, 
Hospital 
anxiety 
and 
depression 
scale, Brief 
illness 
perception 
questionna
ire, AF 
QOL 
questionna
ire, Patient 
knowledge 
questionna
ire. No 
reliability 
data given. 
Education 
improved INR 
control (time 
in therapeutic 
range). 
Analyzed via 
Rosendaal 
method.  
 
Increase in 
anxiety and 
depression 
over time in 
both groups. 
Analyzed with 
Mann Whitney 
U test.  
Mainly 
white 
participants. 
Small 
sample size.  
 
Realistic 
use.  
Aronix 
(2017). 
Health 
literacy and 
atrial 
fibrillation: 
Relevance 
and future 
directions for 
patient-
centered care. 
European 
Summarize 
clinical 
relevance 
of health 
literacy in 
AF and 
strategies 
to improve 
patient 
experience 
for patients 
with 
limited 
Quantitative study, 
Level IV evidence. 
Variables: 
readability and 
grade level of 
selected patient-
reported tools and 
online patient 
education.  
6 patient-
reported 
tools and 12 
webpages 
with AFib 
education. 
Purposive 
sampling.  
Evaluated 
each tool 
and online 
materials 
according 
to Flesh-
Kincaid 
grade 
level, 
Simple 
Measures 
of 
Gobbledyg
Evaluation 
suggested that 
most education 
was at a 
middle-school 
reading level 
and some was 
written at a 
college or 
graduate level 
reading 
capacity.  
 
Data 
collected 
regarding 
readability 
could be 
limited, 
especially 
for older 
adults, 
racial 
minorities, 
and lower 
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Cardiology 
Review. 
health 
literacy 
and AF.  
ook, Dale-
Chall 
Readabilit
y, and 
Estimated 
Lexile 
Measure.  
 
No 
reliability 
data given.  
None of the 
tools that were 
examined met 
the 
qualifications 
for use with 
patients with 
limited health 
literacy.  
income 
individuals.  
Reading 
(2017). 
Health 
literacy and 
awareness of 
atrial 
fibrillation. 
Journal of the 
American 
Heart 
Association. 
Examine 
association 
between 
health 
literacy 
and 
awareness 
of atrial 
fibrillation 
diagnosis.  
Quantitative level 
III evidence, single 
quantitative study 
without 
randomization. 
Variables: Health 
literacy, patient 
knowledge.  
12517 
participants 
Convenienc
e purposive 
sampling 
from 
patients at 
Kaiser 
Permanente 
Northern 
and 
Southern 
California 
healthcare 
systems.  
Patient 
completed 
questionna
ire via mail 
or 
telephone 
interview. 
Questionna
ire 
previously 
validated 
among 
patients in 
a VA study 
regarding 
literacy. 
Overall 
performan
ce values 
for each 
question 
fell within 
the 95% 
CI.  
20 percent of 
patients 
completing the 
questionnaire 
displayed 
inadequate 
health literacy. 
Lower 
socioeconomic 
status, older, 
female 
common 
demographic 
findings.  
 
Analysis: 
Wilcoxon test, 
regression 
analyses.  
Self-
reported 
nature of 
questionnair
e, those 
with 
inadequate 
health 
literacy less 
likely to 
complete 
questionnair
e.  
 
Results 
validated 
relationship 
between AF 
awareness/s
elf-care and 
health 
literacy.  
Rolls (2017). 
The 
relationship 
between 
knowledge, 
health 
literacy, and 
adherence 
among 
patients 
taking oral 
anticoagulant
s for stroke 
theomboprop
hylaxis in 
atrial 
fibrillation. 
Cardiovascul
ar 
Therapeutics. 
Investigate 
relationshi
ps between 
anticoagul
ant 
knowledge
, health 
literacy, 
and self-
reported 
adherence 
in patients 
taking 
warfarin 
and 
DOACs.  
Quantitative, level 
IV evidence, cross-
sectional survey. 
Variables: 
anticoagulation 
knowledge, health 
literacy, medication 
adherence.  
48 
participants, 
convenience 
sampling 
from 
outpatient 
cardiology 
or general 
practice 
clinics in 
Australia.  
Anticoagul
ation 
Knowledg
e Test used 
to assess 
knowledge
.  
 
Short Test 
of 
Functional 
Health 
Literacy in 
Adults to 
assess 
health 
literacy. 
 
Morisky 
Medication 
Adherence 
Significant 
correlation 
between health 
literacy, OAC 
knowledge, 
and adherence. 
Significant 
gaps in OAC 
knowledge.  
Cross-
sectional 
methodolog
y, small 
sample size, 
no 
information 
regarding 
quality of 
education 
previously 
received by 
patients.  
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Scale 8 
item tool 
to assess 
medication 
adherence.  
 
No 
reliability 
data 
available 
for any of 
these tools.  
Noseworthy 
(2018). 
Shared 
decision-
making in 
atrial 
fibrillation: 
navigating 
complex 
issues in 
partnership 
with the 
patient. 
Journal of 
International 
Cardiac 
Electrophysio
logy. 
Discuss 
most 
recent 
guidelines 
for shared 
decision-
making in 
antithromb
otic care 
and 
upcoming 
RCT to 
test a 
decision 
aide for 
providers 
and 
patients 
with atrial 
fibrillation 
and 
anticoagul
ation.  
Qualitative, level 
VII study. Provides 
overview of 
upcoming 
randomized clinical 
trial. No variables.  
None None Shared 
decision 
making tools 
can foster open 
communicatio
n between 
patients and 
providers. 
Helps to 
identify the 
best treatment 
option for 
patients.  
None 
O’Neill 
(2017). 
Availability 
of patient 
decision aids 
for stroke 
prevention in 
atrial 
fibrillation: A 
systematic 
review. 
American 
Heart 
Journal. 
Examine 
existence 
and 
accessibilit
y of 
current 
patient 
decision 
aids for 
stroke 
prevention 
in atrial 
fibrillation.  
Quantitative, level I 
evidence, 
systematic review.  
Six 
databases 
searched 
from 
inception to 
March 2016. 
7 studies 
were 
included. 
Six decision 
aids were 
evaluated.  
Studies 
were 
assessed 
for a 
selection 
of metrics: 
patient 
knowledge
, 
involveme
nt, choice, 
and 
decisional 
conflict.  
 
No 
reliability 
data.  
Need for 
continued 
improvement 
of shared 
decision 
making tools.  
No 
limitations 
for this 
systematic 
review.  
Kunneman 
(2017). 
Shared 
Examine 
study 
protocol 
Qualitative, level 
VII study. Provides 
None 
 
None Goal of study 
is to produce a 
valid and 
None 
ATRIAL FIBRILLATION PATIENT EDUCATION  
 
48
decision 
making for 
stroke 
prevention in 
atrial 
fibrillation: 
study 
protocol for a 
randomized 
controlled 
trial. Trials. 
for 
Anticoagul
ation 
Choice 
conversati
on tool to 
foster 
shared 
decision 
making in 
patients 
with atrial 
fibrillation.  
study protocol for 
upcoming RCT.  
 
Study design for 
RCT will be Level 
II evidence.  
RCT 
examined 
will take 
place at 3 
hospital 
sites in 
Minnesota.  
precise 
measure of the 
effect of the 
Anticoagulatio
n Choice 
conversation 
tool on shared 
decision 
making quality 
and processes.  
Siouta 
(2016). 
Patients’ 
experiences 
of 
communicati
on and 
involvement 
in decision-
making about 
atrial 
fibrillation 
treatment in 
consultations 
with nurses 
and 
physicians. 
Scandinavian 
Journal of 
Caring 
Sciences. 
Examine 
patient 
perception 
of 
involveme
nt and 
communic
ations 
regarding 
AF 
treatment 
in consult 
with 
healthcare 
team.  
Qualitative, level 
VI evidence, single 
qualitative/descripti
ve study. Variables: 
patient experiences 
via open ended 
interview 
questions.  
22 
participants. 
Convenienc
e purposive 
sampling 
from 
patients at 
six 
cardiology 
outpatient 
clinics in 
southern 
Sweden.  
Interviews 
were 
transcribed
. Data was 
coded to 
derive 
common 
themes.  
 
No 
reliability 
data 
available 
for open-
ended 
questions.  
Overall, 
patients feel 
involved in 
consult with 
nurses. With 
physicians, 
patients feel 
involved when 
feeling 
understood and 
acquiring 
knowledge 
about AF 
diagnosis. 
Patients desire 
open 
communicatio
n with 
providers to 
feel included 
in the 
treatment plan.  
 
No analysis 
data.  
Interviews 
performed 
directly 
after the 
consultation
. 
Transferabil
ity of data 
does not 
represent all 
patient 
groups.  
 
Provides 
data to 
support the 
needs of 
patients 
with newly 
diagnosed 
AF.  
Macle (2016). 
Editorial: 
Evidence-
based 
anticoagulatio
n decision 
making for 
atrial 
fibrillation-
How we are 
doing? 
Canadian 
Journal of 
Cardiology. 
Editorial 
review of 
article 
regarding 
practice 
patterns in 
primary 
care for 
patients 
with AF.  
Qualitative 
evidence, Level VII 
study. No variables 
were analyzed.  
One study 
was 
examined 
that 
reviewed the 
practices of 
AF 
management 
amongst 
primary care 
providers. 
No 
reliability 
data for 
this article.  
Study that was 
reviewed 
highlights the 
need for 
standardized 
risk 
assessment 
tools for 
primary care 
physicians to 
use for patients 
with atrial 
fibrillation. 
There is a need 
for an 
individualized 
assessment and 
plan for each 
No explicit 
limitations 
given.  
 
Student 
researcher 
notes the 
low level of 
evidence 
and review 
of a single 
article 
creates a 
low impact 
for project.  
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patient with 
AF.  
Pandya 
(2016). 
Assessment 
of web-based 
education 
resources 
informing 
patients about 
stroke 
prevention in 
atrial 
fibrillation. 
Journal of 
Clinical 
Pharmacy 
and 
Therapeutics. 
Identify 
aspects of 
anticoagul
ant 
treatment 
described 
in existing 
online 
resources 
and how 
this 
informatio
n may 
guide 
patient 
preference
s.  
Qualitative study, 
Level VI evidence. 
Variables: did 
resource provide 
unbiased 
information and 
discuss objectively 
bleeding risk and 
stroke risk.   
33 studies 
utilized in 
analysis. 
Purposive 
sampling. 
Utilized 
Google, 
Yahoo, Ask, 
and Bing 
search 
engines.  
Evaluated 
at 
manifest/s
urface 
level to 
determine 
if 
informatio
n was 
appropriate 
and at the 
latent 
level- 
interpretati
on of data 
presented 
on each 
webpage.  
 
No 
reliability 
data given.  
Four themes 
from manifest 
analysis: 
Pharmacothera
puetics for AF 
stroke 
prevention, 
antithrombotic 
management, 
anticoagulant 
therapy 
management, 
and risk-
benefit 
awareness. 
 
3 themes from 
latent level 
analysis: 
Practical ease 
of managing 
NOACs over 
warfarin, 
unbalanced 
explanation 
about stroke 
risk versus 
bleeding risk, 
and 
individualized 
OAC 
selection.  
Search 
restricted to 
English 
language 
only. 
Newsletters 
and periodic 
articles not 
included in 
search. 
Internationa
l domains 
not 
covered-
only AU 
online 
domain.  
 
Easily 
replicated.  
Xureb (2016). 
Patients’ and 
physicians’ 
experiences 
of atrial 
fibrillation 
consultations 
and 
anticoagulatio
n decision-
making: A 
multi-
perspective 
IPA design. 
Psychology & 
Health. 
Explore 
patient and 
physician 
experience
s of AF 
consultatio
ns and oral 
anticoagul
ation 
decision-
making.  
Qualitative, level 
VI design, single 
descriptive study. 
Variables: 
interview 
responses.  
25 
participants 
(patients and 
physicians). 
Purposive 
sampling.  
Interviews 
using open 
ended 
questions. 
Interviews 
were 
recorded 
and 
transcribed
. Analyzed 
for 
common 
themes.  
 
No 
reliability 
data.  
Patients desire 
the opportunity 
to make an 
informed 
decision and 
would like the 
tools to make 
this decision. 
Providers are 
concerned with 
delivery of 
information in 
most effective 
manner.  
 
Limited 
interview 
time, small 
sample size.  
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Appendix C: PRISMA Diagram 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Additional records identified 
through other sources  
(n = 5) 
Records identified through 
database searching 
(n =30) 
Records after duplicates 
removed 
(n = 35) 
Records screened 
(n =35) 
Records excluded 
 (n =0) 
Full-text articles assessed for 
eligibility 
 (n =35) 
Full-text articles excluded 
with reasons 
 (n =9) 
Studies included in synthesis 
of evidence 
(n = 24) 
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Appendix D: Theory to Application Diagram 
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Appendix E: Cost Table for Project 
Item Item 
Description 
Quantity Unit Cost Anticipated 
Cost 
Actual 
Cost 
1 Print materials: 
Pre and post 
test 
questionnaires 
and QR code 
cards 
50 2.00 $100.00 $0 (covered 
by clinic 
with 
manager 
approval) 
2 Mobile 
application 
download via 
application 
store 
40 0.00 $0 $0 
3 Clinic Room 
Use 
N/A 0.00 $0 $0 
4 Student Time 165 hours N/A $0 $0 
   Total $100.00 $0 
 
 
Dissemination Costs 
Item Description Unit Cost TOTAL  
1 APNO Registration $150 $150 
2 APNO Hotel/Travel 
Expenses 
$200 $350 
3 APNO Poster Printing $50 $400 
4 MNRS Registration $200 $600 
5 MNRS Travel Expenses 
Non-Refundable 
$200 $800 
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Appendix F: Project Timeline Flow Graphic 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data analysis 
using REDCap 
system.  
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Appendix G: Intervention Flow Diagram 
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Appendix H: Logic Model 
Logic Model for DNP Project   
Student: Jamie Parks 
Inquiry, PICOTS: In patients age 40-75 with newly diagnosed atrial fibrillation within the last year, does education 
provided via the CardioVisual mobile app, compared to current education provided by Heart Rhythm Society 
brochures, increase patient knowledge of atrial fibrillation and improve anticoagulation adherence in three 
months at a cardiology clinic? 
Inputs 
 Intervention(s)                        
Outputs 
 
Outcomes – Impact 
 Activities Participation  Short Medium Long 
Evidence, sub-
topics 
1. Patient 
experience and 
baseline 
knowledge 
2. Health 
literacy 
3. Shared 
decision-making 
 
Major 
Facilitators or 
Contributors 
1. Minimal cost 
for project 
implementation 
2. Minimal time 
required for 
others during 
implementation 
3. Sustainability 
after DNP 
project is 
complete 
4. Support of 
stakeholders 
including 
electrophysiolog
y MDs and 
APPs 
 
Major Barriers 
or Challenges 
1. Participants 
not having a 
smart phone 
 EBP 
interventio
n: 
Intervention 
group 
receives 
standard 
education 
and access 
to 
CardioVisual 
mobile 
application. 
Pre/post test 
for 
knowledge 
assessment 
and 
medication 
adherence.  
 
Major steps 
of the 
interventio
n (brief 
phrases) 
1. Recruit 
patients 
2. Pre-tests 
given to 
participants 
after office 
visit with 
provider. 
3. 
Educational 
intervention 
carried out. 
The 
participants: 
Patients newly 
diagnosed with 
AF in the last 
year who are age 
40-75 that are 
seeing an 
electrophysiologi
st in consult for 
AF. Sample size: 
30 patients 
divided into 2 
groups: Control 
and intervention.  
 
Site: Two 
cardiology clinics 
in Kansas City, 
MO 
 
Time Frame: 4 
total months; one 
month to recruit 
participants and 
complete 
baseline 
education 
intervention, then 
follow up at 3 
months. 
 
Consent or 
assent Needed: 
Yes- consent will 
be obtained prior 
to intervention 
 
 (Completed 
during DNP 
Project)  
 
Outcome(s) 
to be 
measured 
Primary: 
Patient 
knowledge   
 
Secondary: 
Anticoagulatio
n adherence    
 
 
Measuremen
t tool(s) 
1.Jessa Atrial 
Fibrillation 
Knowledge 
Questionnaire 
2. MMAS-8 
tool (modified 
by 
researcher) 
 
Statistical 
analysis to 
be used 
1. Paired t-
test pre and 
post 
2. Descriptive 
statistics  
 
(after student 
DNP)  
 
Outcomes to 
be measured  
 
Patient 
knowledge 
 
Anticoagulatio
n adherence 
 
 
 
 
 
 
 
 
 
 
 
(after student 
DNP) 
 
Outcomes 
that are 
potentials  
 
Reduced 
hospitalization
s due to atrial 
fibrillation 
 
Reduced 
incidence of 
ischemic 
stroke 
 
Increased 
patient 
satisfaction  
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2. Refusal to 
download 
mobile app 
3. Small sample 
size, low effect 
size 
 
 
 
 
4. Follow up 
with post-
tests in 3 
months.  
5.. Analyze 
test results.  
 
Other person(s) 
collecting data: 
No 
 
Others directly 
involved in 
consent or data 
collection: No 
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Appendix I: Data Collection Template 
 
Instrument screenshot from REDCap. This tool was utilized for data collection for this project.  
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Appendix J: Statistical Analysis Results  
 
Jessa Atrial Fibrillation Knowledge Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Measurement of Treatment Adherence 
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Appendix K: Faculty DNP Project Approval Letter  
 
 
